Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
Revolutionary ovarian cancer rapid test available Q4 2022
It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
It affects up to 10 per cent of women of reproductive age around the world
Subscribe To Our Newsletter & Stay Updated
